✦ LIBER ✦

Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study

✍ Scribed by Chris J. Twelves; Charles A. Butts; Jim Cassidy; Thierry Conroy; Filippo de Braud; Eduardo Díaz-Rubio; Josep M. Tabernero; Patrick Schöffski; Arie Figer; René Brunet; Johannes Grossmann; Alberto F. Sobrero; Eric J. Van Cutsem

Book ID: 119934985
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 887 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2005.n.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly oxaliplatin combined with oral

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study

✍ P. Comella; B. Massidda; S. Palmeri; A. Farris; L. De Lucia; D. Natale; L. Maior 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 190 KB

707 PUBLICATION Capecitabine, oxaliplati

707 PUBLICATION Capecitabine, oxaliplatin and irinotecan combination: a first line treatment for metastasic colorectal cancer, preliminary results of a phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Phase I/II study of oxaliplatin with ora

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer

✍ Yamada, Y; Tahara, M; Miya, T; Satoh, T; Shirao, K; Shimada, Y; Ohtsu, A; Sasaki 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Capecitabine in combination with oxalipl

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study

✍ Twelves, C.; Butts, C.; Cassidy, J.; Conroy, Th.; DeBraud, F.; Díaz-Rubio, E.; F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Results of a Phase II Trial of Cetuximab

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB